Watchlist Manager

Watchlist

Price: 41.17 INR -0.34% Market Closed

Market Cap: ₹22.6B

	Morepen Laboratories Ltd NSE:MOREPENLAB	IN
	Eclerx Services Ltd NSE:ECLERX	IN
	Redwoods Acquisition Corp NASDAQ:WENA	US
P	Photon Capital Advisors Ltd BSE:509084	IN
	Nyfosa AB STO:NYF	SE

Balance Sheet

Currency: INR

	Mar-2001	Mar-2002	Sep-2003	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	806	475	710	693	710	681	149	38	8	15	34	44	55	54	36	70	57	96	136	414	147	217	169	274
Cash	806	475	710	693	710	681	149	38	8	15	34	44	55	54	36	70	57	96	136	414	147	217	169	274
Short-Term Investments	84	92	32	2	2	1	4	8	3	0	0	0	0	0	0	0	2	0	0	0	11	0	144	778
Total Receivables	1 867	2 558	2 777	2 936	2 924	186	213	358	348	355	421	464	486	602	1 010	1 092	1 427	1 545	1 546	2 150	2 932	2 978	3 561	3 968
Accounts Receivables	1 015	1 431	1 302	1 432	1 390	104	24	19	22	21	21	20	427	561	880	930	1 219	1 337	1 377	1 820	2 506	2 642	3 265	3 259
Other Receivables	852	1 127	1 475	1 504	1 534	82	189	339	326	334	400	444	59	41	130	162	208	208	169	330	426	336	296	708
Inventory	787	1 110	780	797	849	181	191	223	317	402	427	390	352	426	513	746	938	1 119	1 773	2 427	3 925	3 946	4 627	5 573
Other Current Assets	7	118	43	184	56	43	41	20	24	28	13	12	71	64	13	11	10	235	266	277	329	421	533	1 001
Total Current Assets	3 551	4 353	4 342	4 614	4 542	1 093	598	647	700	800	896	911	963	1 146	1 571	1 919	2 434	2 995	3 722	5 268	7 343	7 562	8 890	11 594
PP&E Net	5 286	6 747	7 483	6 786	6 366	5 909	5 447	4 995	4 585	4 170	3 739	3 312	2 896	2 440	2 180	1 934	1 724	1 474	1 341	1 312	1 608	1 840	2 377	3 703
PP&E Gross	5 286	6 747	7 483	6 786	6 366	5 909	5 447	4 995	4 585	4 170	3 739	3 312	2 896	2 440	0	1 934	1 724	1 474	1 341	1 312	1 608	1 840	2 377	3 703
Accumulated Depreciation	544	847	1 464	2 154	2 635	3 102	3 572	3 907	4 358	4 798	5 223	5 677	6 131	6 632	0	7 309	7 060	6 179	4 955	3 710	3 166	3 289	2 614	2 758
Intangible Assets	0	122	0	0	181	169	153	60	37	11	0	3	6	5	4	4	174	144	78	208	307	255	197	720
Goodwill	0	0	0	0	779	779	779	779	779	779	779	779	779	779	780	780	745	745	745	745	745	745	745	745
Note Receivable	0	0	0	0	0	0	0	0	0	14	16	17	251	519	167	158	778	792	736	1 035	637	637	637	867
Long-Term Investments	1 208	578	711	710	40	40	40	40	40	40	39	39	0	0	8	6	0	0	11	11	58	64	84	149
Other Long-Term Assets	18	259	1 831	4 196	3 092	4 123	4 596	601	628	0	0	0	0	0	527	582	3	3	3	3	3	3	2	2
Other Assets	0	0	0	0	779	779	779	779	779	779	779	779	779	779	780	780	745	745	745	745	745	745	745	745
Total Assets	10 063 N/A	12 059 +20%	14 367 +19%	16 306 +13%	15 001 -8%	12 113 -19%	11 614 -4%	7 122 -39%	6 769 -5%	5 814 -14%	5 470 -6%	5 061 -7%	4 895 -3%	4 890 0%	5 237 +7%	5 383 +3%	5 858 +9%	6 152 +5%	6 635 +8%	8 581 +29%	10 701 +25%	11 105 +4%	12 932 +16%	17 781 +37%
Liabilities
Accounts Payable	63	161	521	506	644	696	706	775	818	598	650	568	686	850	1 154	1 249	1 749	1 682	1 723	2 088	2 581	2 269	2 950	3 633
Accrued Liabilities	91	60	55	0	0	0	0	0	0	94	92	121	81	98	176	180	110	130	153	198	207	249	288	277
Short-Term Debt	12	132	30	17	1	1	0	3	4	0	0	0	12	22	0	0	0	90	114	153	161	232	235	460
Current Portion of Long-Term Debt	0	0	0	0	0	0	0	0	0	42	70	166	133	164	1 361	1 673	1 313	1 208	1 208	1 205	11	11	21	198
Other Current Liabilities	672	276	25	27	27	28	25	31	31	294	237	172	170	145	169	147	230	283	316	392	1 604	452	526	438
Total Current Liabilities	837	629	631	550	672	726	731	809	852	1 028	1 050	1 027	1 081	1 279	2 860	3 249	3 401	3 392	3 514	4 038	4 565	3 212	4 020	5 007
Long-Term Debt	4 508	6 020	9 205	9 327	8 890	4 836	2 920	2 798	1 385	1 287	1 139	947	748	623	511	14	29	18	9	8	13	9	34	392
Deferred Income Tax	0	1 123	0	1 683	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25	27	22	70
Minority Interest	0	2	2	2	1	3	3	4	4	4	4	4	4	4	6	6	5	5	5	5	5	5	0	307
Other Liabilities	0	0	71	115	120	148	3	6	13	63	82	93	99	117	141	164	173	215	275	292	317	333	383	443
Total Liabilities	5 345 N/A	7 774 +45%	9 910 +27%	11 677 +18%	9 681 -17%	5 707 -41%	3 652 -36%	3 610 -1%	2 245 -38%	2 374 +6%	2 266 -5%	2 062 -9%	1 924 -7%	2 015 +5%	3 505 +74%	3 420 -2%	3 599 +5%	3 621 +1%	3 794 +5%	4 334 +14%	4 915 +13%	3 576 -27%	4 460 +25%	6 219 +39%
Equity
Common Stock	557	489	514	525	645	645	1 912	1 912	2 097	2 097	2 097	2 097	2 096	2 096	900	900	900	900	900	900	956	1 022	1 022	1 096
Retained Earnings	1 822	1 456	979	1 045	1 075	2 162	818	789	753	330	566	771	799	895	841	605	309	21	315	1 723	2 565	2 877	3 839	5 019
Additional Paid In Capital	2 339	2 340	2 965	3 060	3 600	3 600	5 233	812	1 674	1 674	1 674	1 674	1 674	1 674	1 674	1 674	1 674	1 674	1 674	1 674	2 318	3 698	3 698	5 532
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6	5	22	48	50	53	68	86	84
Total Equity	4 718 N/A	4 285 -9%	4 457 +4%	4 629 +4%	5 319 +15%	6 406 +20%	7 962 +24%	3 512 -56%	4 524 +29%	3 441 -24%	3 204 -7%	2 999 -6%	2 971 -1%	2 875 -3%	1 732 -40%	1 963 +13%	2 259 +15%	2 531 +12%	2 841 +12%	4 247 +49%	5 786 +36%	7 529 +30%	8 472 +13%	11 562 +36%
Total Liabilities & Equity	10 063 N/A	12 059 +20%	14 367 +19%	16 306 +13%	15 001 -8%	12 113 -19%	11 614 -4%	7 122 -39%	6 769 -5%	5 814 -14%	5 470 -6%	5 061 -7%	4 895 -3%	4 890 0%	5 237 +7%	5 383 +3%	5 858 +9%	6 152 +5%	6 635 +8%	8 581 +29%	10 701 +25%	11 105 +4%	12 932 +16%	17 781 +37%
Shares Outstanding
Common Shares Outstanding	91	90	141	151	211	211	357	357	450	450	450	450	450	450	450	450	450	450	450	450	478	511	511	548
Preferred Shares Outstanding	4	4	2	2	2	2	12	12	12	12	12	12	12	12	12	12	12	12	12	12	11	0	0	0

Income Statement Balance Sheet Cash Flow Statement

Morepen Laboratories Ltd
NSE:MOREPENLAB

Balance Sheet

Balance Sheet Decomposition
Morepen Laboratories Ltd

Balance Sheet
Morepen Laboratories Ltd

See Also

Company

Help

Tools

Stocks

Morepen Laboratories Ltd NSE:MOREPENLAB

Balance Sheet

Balance Sheet Decomposition Morepen Laboratories Ltd

Balance Sheet Morepen Laboratories Ltd

See Also

Company

Help

Tools

Stocks

Morepen Laboratories Ltd
NSE:MOREPENLAB

Balance Sheet Decomposition
Morepen Laboratories Ltd

Balance Sheet
Morepen Laboratories Ltd